Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-10

Clinical Trial Update: A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pomalidomide monotherapy in children and young adults with recurrent or progressive primary brain tumors, including medulloblastoma; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pomalidomide (Pomalidomide)

Snippet

Sponsor: Celgene | Conditions: Central Nervous System Neoplasms, Medulloblastoma | Phase 2 | Status: COMPLETED | Results posted: 2019-12-10